1. ATHENA VS HEPHAISTOS - ARE DISCONTINUATION RATES IN MULTICENTER STUDIES DRIVEN BY FACTS OR ATTITUDES?. Issue 3 (September 2020) Authors: Nashan, Björn; Braun, Felix; Dragun, Duska; Hauser, Ingeborg A.; Schemmer, Peter; Schlitt, Hans J.; Sommerer, Claudia; Suwelack, Barbara; Schiedel, Christiane; Kroeger, Irena; Thaiss, Friedrich Journal: Transplantation Issue: Volume 104:Issue 3(2020) Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. COUNTRY-DEPENDENT OUTCOME DIFFERENCES AFTER KIDNEY TRANSPLANTATION IN FRANCE VS. GERMANY – AN ADDITIONAL ANALYSIS OF THE ATHENA STUDY. Issue 3 (September 2020) Authors: Suwelack, Barbara; Thaiss, Friedrich; Sommerer, Claudia; Dragun, Duska; Hauser, Ingeborg A.; Witzke, Oliver; Hugo, Christian; Schenker, Peter; Merville, Pierre; Kamar, Nassim; Kroeger, Irena; Junge, Martina; Nashan, Björn Journal: Transplantation Issue: Volume 104:Issue 3(2020) Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. De novo mTOR inhibitor‐based immunosuppression in ABO‐incompatible kidney transplantation. (5th October 2015) Authors: Koch, Martina; Wiech, Thorsten; Marget, Matthias; Peine, Sven; Thude, Hansjörg; Achilles, Eike G.; Fischer, Lutz; Lehnhardt, Anja; Thaiss, Friedrich; Nashan, Bjoern Journal: Clinical transplantation Issue: Volume 29:Number 11(2015) Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Design and rationale of the ATHENA study – A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. Issue 1 (December 2016) Authors: Sommerer, Claudia; Suwelack, Barbara; Dragun, Duska; Schenker, Peter; Hauser, Ingeborg; Nashan, Björn; Thaiss, Friedrich Journal: Trials Issue: Volume 17:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of everolimus‐based drug regimens on CMV‐specific T‐cell functionality after renal transplantation: 12‐month ATHENA subcohort‐study results. Issue 4 (28th December 2020) Authors: Hauser, Ingeborg A.; Marx, Stefanie; Sommerer, Claudia; Suwelack, Barbara; Dragun, Duska; Witzke, Oliver; Lehner, Frank; Schiedel, Christiane; Porstner, Martina; Thaiss, Friedrich; Neudörfl, Christine; Falk, Christine S.; Nashan, Björn; Sester, Martina Journal: European journal of immunology Issue: Volume 51:Issue 4(2021) Page Start: 943 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Four‐year allograft survival in a highly sensitized combined liver–kidney transplant patient despite unsuccessful anti‐HLA antibody reduction with rituximab, splenectomy, and bortezomib. (15th May 2013) Authors: Koch, Martina; Gräser, Christian; Lehnhardt, Anja; Pollok, Jörg M.; Kröger, Nikolaus; Verboom, Murielle; Thaiss, Friedrich; Eiermann, Thomas; Nashan, Björn Journal: Transplant international Issue: Volume 26:Number 8(2013:Aug.) Page Start: e64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. High B‐cell activating factor is not associated with worse 3‐year graft outcome in blood group‐incompatible kidney transplantation with rituximab induction. (18th February 2015) Authors: Lehnhardt, Anja M.; Strecker, Maximiliane; Eiermann, Thomas; Marget, Matthias; Thaiss, Friedrich; Nashan, Björn; Koch, Martina Journal: Clinical transplantation Issue: Volume 29:Number 4(2015) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Incidence of BK polyomavirus infection after kidney transplantation is independent of type of immunosuppressive therapy. Issue 6 (30th November 2016) Authors: Radtke, Josephine; Dietze, Nina; Fischer, Lutz; Achilles, Eike‐Gert; Li, Jun; Scheidat, Silke; Thaiss, Friedrich; Nashan, Bjoern; Koch, Martina Journal: Transplant infectious disease Issue: Volume 18:Issue 6(2016) Page Start: 850 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Induction therapy with rabbit antithymocyte globulin versus basiliximab after kidney transplantation: a health economic analysis from a German perspective. (24th July 2017) Authors: Cremaschi, Liana; von Versen, Regina; Benzing, Thomas; Wiesener, Michael; Zink, Nikolai; Milkovich, Gary; Paivanas, Thomas; Gallagher, Meghan; Thaiss, Friedrich Journal: Transplant international Issue: Volume 30:Number 10(2017) Page Start: 1011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Innate Immune Response in Kidney Ischemia/Reperfusion Injury: Potential Target for Therapy. (6th June 2017) Authors: Kezić, Aleksandra; Stajic, Natasa; Thaiss, Friedrich Other Names: Ke Bibo Academic Editor. Journal: Journal of immunology research Issue: Volume 2017(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗